• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Packaging Technology

    Elemental Impurities: The Time Has Come

    Continuous vs. Batch Production

    2018: The evolution of pharmaceutical packaging

    Formulation Development Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    InClinica Names BD Manager

    SCHOTT Introduces syriQ BioPure

    Heritage Pharma Makes Leadership Changes

    JLL and Water Street Acquire Triplefin

    WuXi AppTec Opens Laboratory Testing Facility in NJ
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    WuXi AppTec Opens Laboratory Testing Facility in NJ

    Arcinova Receives £1.5M Innovate UK Grant

    Vetter Welcomes Illinois Governor

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    Almac Group Expands Packaging Capabilities

    Catalent Bolsters Clinical Supply Capabilities

    West, Stevanato Group Enter Ompi EZ-fill Alliance

    Pharmaceutical Packaging Technology
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    WuXi AppTec Opens Laboratory Testing Facility in NJ

    ICON, Intel Enter Pharma Analytics Platform Pact

    AMRI Renews NIH Contract

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Blockchain: The Next Big Trend in BioPharma?

    Emergent Completes Market Authorization

    Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle: ICH Q12

    LSNE Expands Capabilities and QC Laboratory Space

    Evotec Launches Drug Development Service
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    Adaptive Clinical Systems

    IQVIA

    Dow Development Laboratories, LLC

    Piramal Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    The Changing Biopharma Risk Landscape

    Highlights biopharma industry's growth drivers and new approaches for mitigating risk

    Related CONTENT
    • 2014 - Fifteenth Annual Salary and Job Satisfaction Survey
    • Videos from INTERPHEX: Overcoming Packaging Challenges with Particulates
    • Banging the CMO Drum
    • GW Pharmaceuticals CEO: Cannabis As A Cure | Mad Money | CNBC
    • The Changing Biopharma Risk Landscape
    06.13.16
    At the 2016 BIO International Convention in San Francisco, CA, MilliporeSigma unveiled survey results of 250 global biopharmaceutical executives on how their companies will manage new risks associated with the changing biopharma landscape. The survey, sponsored by MilliporeSigma, was conducted by the Economist Intelligence Unit (EIU), a leading resource for economic and business research, forecasting and analysis.

    "In response to the uncertainty and disruption facing the biopharmaceutical industry, MilliporeSigma has moved beyond old risk-management models and has adopted and is applying new strategies at the earliest stages of development and seeing them through to commercialization," said Udit Batra, member, executive board, Merck KGaA, and chief executive officer, MilliporeSigma.

    According to the study, 48 percent of respondents are developing or will develop novel therapies, such as gene and cell therapies, while the biopharma firms interviewed said they anticipate entering South Korea, Indonesia and Taiwan in the next five years.

    Regulatory uncertainty tops the list of risks that biopharma executives think might disrupt their company's strategy in the next five years (32 percent).

    At the same time, 80 percent of respondents are highly optimistic about their company's ability to bring new drug products to market over the next five years.

    Manufacturers in the biopharma industry face unprecedented challenges as they enter unfamiliar geographies, aggressively replenish pipelines and expand into novel areas such as gene and cell therapies requiring more complex development and production. The EIU study examines how new growth strategies are creating exposure to different types of risk and explores options for successfully navigating this unexplored territory.

    Survey respondents offered a global view with 31 percent from Europe, 30 percent from North America, 29 percent from Asia and 10 percent from the rest of the world. Responses also reflect the differences in view depending on company size, with 50 percent of participants coming from biopharmas with less than $500 million in revenues and 50 percent from larger players.

    To download the report, visit www.gobeyondbiopharma.com.   
    Related Searches
    • study
    • chief executive officer
    • production
    • Biopharma
    Suggested For You
    Merck, Stelis Open First Joint Process Scale-Up Lab in Bengaluru Merck, Stelis Open First Joint Process Scale-Up Lab in Bengaluru
    MilliporeSigma Develops New CRISPR Genome Editing Method MilliporeSigma Develops New CRISPR Genome Editing Method
    MilliporeSigma, SystImmune Partner for Bi-specific Antibody Development MilliporeSigma, SystImmune Partner for Bi-specific Antibody Development
    Avid Bioservices Expands Manufacturing Capacity Avid Bioservices Expands Manufacturing Capacity
    MilliporeSigma, LabCentral to Foster Biotech Startups MilliporeSigma, LabCentral to Foster Biotech Startups
    MilliporeSigma Introduces Next-Gen High-Sensitivity Protein Detection Platform MilliporeSigma Introduces Next-Gen High-Sensitivity Protein Detection Platform
    MilliporeSigma Offers Fully Integrated ADC Services MilliporeSigma Offers Fully Integrated ADC Services
    MilliporeSigma Opens Production Facility in Spain MilliporeSigma Opens Production Facility in Spain
    MilliporeSigma Expands Biodevelopment Centers MilliporeSigma Expands Biodevelopment Centers
    DCAT Launches Networking Event in Barcelona to Serve Expanding Global Membership DCAT Launches Networking Event in Barcelona to Serve Expanding Global Membership
    The Changing Biopharma Risk Landscape The Changing Biopharma Risk Landscape
    GW Pharmaceuticals CEO: Cannabis As A Cure | Mad Money | CNBC GW Pharmaceuticals CEO: Cannabis As A Cure | Mad Money | CNBC
    Banging the CMO Drum
Banging the CMO Drum
    Videos from INTERPHEX: Overcoming Packaging Challenges with Particulates Videos from INTERPHEX: Overcoming Packaging Challenges with Particulates
    2014 - Fifteenth Annual Salary and Job Satisfaction Survey 2014 - Fifteenth Annual Salary and Job Satisfaction Survey

    Related Online Exclusives

    • Advancing Rare Disease Research

      Advancing Rare Disease Research

      How early research provides the crucial evidence needed to conduct clinical trials
      Kristin Brooks, Contract Pharma 03.05.18

    • Biologic Sample Management in R&D

      Biologic Sample Management in R&D

      Vyas of PAREXEL discusses the significance of biologic samples, sample management challenges and the regulatory implications
      Kristin Brooks, Managing Editor 02.15.18

    • Outsourcing Early Drug Development

      Outsourcing Early Drug Development

      Birgit Girshick of Charles River discusses trends in the early discovery and development space
      01.17.18


    • Major Changes for Bio Supply Forecast in 2018

      Major Changes for Bio Supply Forecast in 2018

      Integration of supply chain a critical issue as industry globalizes
      01.12.18

    • Closing the Gap in Real-World Evidence

      Closing the Gap in Real-World Evidence

      PAREXEL's Joshua Schultz discusses research challenges and the need for standards to overcome RWE limitations
      Kristin Brooks, Contract Pharma 12.04.17

    • Facilities | Serialization | Supply Chain
      Vetter Expands Secondary Packaging Capacities

      Vetter Expands Secondary Packaging Capacities

      The 32,000 square foot expansion will include new state-of-the art packaging lines and assembly equipment
      11.27.17


    • cGMP Manufacture
      Advantages of Fixed-Dose Combo Drug Products

      Advantages of Fixed-Dose Combo Drug Products

      Dr. Anthony Qu of Halo discusses opportunities in this growing market
      Kristin Brooks, Contract Pharma 11.14.17

    • AAPS Annual Meeting Preview

      AAPS Annual Meeting Preview

      Sessions address Pharmaceutical Excipients, Emerging Partnership Models, Drug Delivery Strategies, and more
      11.01.17

    • APIs
      Frankfurt Hosts CPhI Worldwide 2017

      Frankfurt Hosts CPhI Worldwide 2017

      ICSE expo features 300 pharmaceutical outsourcing service providers, business development forum, networking, and sessions
      10.13.17


    • cGMP Manufacture | Regulatory Affairs
      Contracting & Outsourcing Session Highlights and Key Takeaways

      Contracting & Outsourcing Session Highlights and Key Takeaways

      Insight into CMO Trends, Biotrends, Manufacturing Compliance, FDA Quality Agreements, and CMO Oversight
      Kristin Brooks, Contract Pharma 10.09.17

    • APIs | cGMP Manufacture
      CMO/CDMO Sector Mega-Mergers & Acquisitions

      CMO/CDMO Sector Mega-Mergers & Acquisitions

      A look at recent M&A activity among contract service providers
      Kristin Brooks, Contract Pharma 10.02.17

    • Filings and Fast Track/Breakthrough Designations

      Filings and Fast Track/Breakthrough Designations

      Sanofi and Regeneron, AbbVie, Sunovion, and more
      09.27.17

    • Cancer Trials in the New Age of Drug Development

      Cancer Trials in the New Age of Drug Development

      Insights into the rapid pace of new drug approvals and the implications for pharma/biopharma companies
      08.21.17

    • cGMP Manufacture
      Modernizing CMO Partnerships

      Modernizing CMO Partnerships

      Leveraging technology to facilitate seamless interactions between CMOs and sponsors
      08.21.17

    • Cell Therapy Industry Update: What to Expect Near-Term

      Cell Therapy Industry Update: What to Expect Near-Term

      Martin Lamb of TrakCel discusses the key players, challenges, and advances in the cell therapy industry
      Kristin Brooks, Contract Pharma 07.10.17

    Breaking News
    • InClinica Names BD Manager
    • SCHOTT Introduces syriQ BioPure
    • Heritage Pharma Makes Leadership Changes
    • JLL and Water Street Acquire Triplefin
    • WuXi AppTec Opens Laboratory Testing Facility in NJ
    View Breaking News >
    CURRENT ISSUE

    April 2018

    • Pharmaceutical Packaging Technology
    • Elemental Impurities: The Time Has Come
    • Continuous vs. Batch Production
    • 2018: The evolution of pharmaceutical packaging
    • Formulation Development Trends
    • Changing Dynamics: The CDMO market in focus
    • Contract BioManufacturing in China: Creating a New Segment
    • View More >

    Copyright © 2018 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.